logo
episode-header-image
Sep 12
34m 51s

214. Dr Narjust Florez and the rise of e...

Michael Fernando and Josh Hurwitz
About this episode
tail spinning
Up next
Sep 7
213. Back to Basics - Early Melanoma
In this episode, Michael and Josh delve into the world of early melanoma. Some may think that melanoma has had its moment in the sun (pun slightly intended) and that other cancer treatments are passing it by. But in this instance, you can teach an old dog new tricks, an old immun ... Show More
28m 49s
Aug 29
212. Back to Basics - Non-Melanoma Skin Cancer
If you like cemiplimab, you will like this episode. Since its introduction, cemiplimab has become the mainstay of treatment for cutaneous SCC, the most common non-melanoma skin cancer likely to attend an oncologist. Cemiplimab's scope is expanding; once reserved purely for the lo ... Show More
24m 48s
Aug 22
211. Back to Basics - Hepatocellular Carcinoma
For over a decade, sorafenib remained unchallenged as first-line therapy for hepatocellular carcinoma, based on the SHARP trial, which showed survival increasing from 7.9 to 10.7 months. This demonstrated modest efficacy in a disease notoriously resistant to systemic treatment. T ... Show More
26m 17s
Recommended Episodes
Aug 2023
Immunotherapy in TNBC: What's New, What's Next?
Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991253). The ... Show More
20m 52s
Oct 2023
Radiation Oncology and the Abscopal Effect in TNBC
What does the cutting edge of radiation oncology look like for treating triple-negative breast cancer? Tune in to hear experts Drs Kevin Kalinsky and Reshma Jagsi discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarti ... Show More
18m 34s
Nov 2023
Hereditary Breast Cancer, Genetic Testing, and Therapeutic Implications
Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991258). The topics and discussions ... Show More
19m 26s
Dec 2023
Thinking Beyond TROP2 at ESMO 2023
What were the biggest takeaways from ESMO 2023 related to TNBC and IBC? Tune in to hear experts Drs Kevin Kalinsky and Filipa Lynce discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991259). The topics and dis ... Show More
17m 6s
Sep 2023
How Do You Optimize Neoadjuvant Therapy Selection?
Join experts Drs Kevin Kalinsky and Priyanka Sharma as they discuss their current approach to neoadjuvant therapy in triple negative breast cancer and how the SCARLET trial might change that. Relevant disclosures can be found with the episode show notes on Medscape (https://www.m ... Show More
21m 14s
Oct 2024
Localized Breast Cancer 2024 UPDATE
<p>This week’s episode  is part 2 of 2024 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status. We are honored to have Dr. Eleonora Teplinsky, a board-certified ... Show More
28m 49s
Oct 2024
Outdated: Cervix Part 2: Locally Advanced Cervical Cancer
This is the second of three episodes covering cervical cancer. In this episode, we define locally advanced, metastatic, and recurrent cervical cancer. We will discuss the standard treatment options, including chemotherapy and immunotherapy choices. Join us for bi-weekly episodes ... Show More
39m 43s
May 2024
Episode 104: Colorectal Cancer Series, Pt. 6 - Colorectal Cancer Pharmacology
<p>We have another guest joining us this week! Dr. Allison Schepers, PharmD, BCOP is a Clinical Pharmacist Specialist at the Rogel Cancer Center at the University of Michigan where she focuses on GI, GU, and Thoracic malignancies! In this episode, Allison discusses the high yield ... Show More
38m 36s
Oct 2008
7. Breast cancer
In this episode, Dr Parveen Boora discusses breast cancer. Topics covered include: approach to the history and physical exam of breast masses indications for breast imaging and biopsy staging invasive cancer management of breast cancer surgery for primary tumors surgery for axill ... Show More
16m 43s
Feb 2022
Special Episode: Ki67 as a Prognostic and Predictive Biomarker in HR-Positive/HER2-Negative Early Breast Cancer
<p>This 45-minute podcast features the expertise of a pathologist and an oncologist highlighting important and practice-changing developments related to the use of Ki67 biomarker testing in patients with HR-positive/HER2-negative early breast cancer, such as new clinical data wit ... Show More
44m 46s